Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Evox Therapeutics Ltd.

Evox Therapeutics is a privately held, Oxford-based biotechnology company focused on harnessing and engineering the natural delivery capabilities of extracellular vesicles, known as exosomes, to develop an entirely new class of biotherapeutics. Backed by Oxford Sciences Innovation and supported by a comprehensive intellectual property portfolio, Evox’s mission is to positively impact human health by creating novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. Evox has created substantial proprietary technology to modify exosomes using various molecular engineering, drug loading, and targeting strategies to facilitate targeted drug delivery to organs of interest, including the brain and the central nervous system. Exosome-based drugs have the potential to address some of the limitations of protein, antibody and nucleic acid-based therapies by enabling delivery to cells and tissues that are currently out of reach using other drug delivery technologies, and Evox is leading the development within this emerging therapeutic space. *


Period Start 2016-01-01 established
Products Industry exosome therapeutic
  Industry 2 drug delivery technology (drug formulation technology)
Person Person de Fougerolles, Antonin (Tony) (Evox Therapeutics 2017– CEO before Ablynx + Moderna Therapeutics + Tolerx + Alnylam)
Region Region Oxford, Oxfordshire
  Country United Kingdom (GB)
  Street Robert Robinson Avenue
Oxford Science Park, Medawar Centre, 2nd Floor East Building
  City OX4 4HG Oxford, Oxfordshire
  Tel +44-1865-819140
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: Evox Therapeutics Ltd.. (3/26/20). "Press Release: Evox Therapeutics and Takeda Sign Multi-target Rare Disease Collaboration".
Record changed: 2021-02-20


Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Evox Therapeutics Ltd.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Hotspot for Startups 650x80px

» top